Acurx Pharmaceuticals
Bookmark
ShareAcurx Pharmaceuticals is a company. It is in Staten Island, the United States and it has a male CEO called David P. Luci. It was founded in 2017 and is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Staten Island
- state: NY
- country: United States
- employees: 3 people
- revenues: Try Pro to see estimate
- sector: Health Care
- industry: Biotechnology
- foundation year: 2017
- CEO: David P. Luci
- CEO gender: male
- ESG score: Try Pro to see estimate
- environmental score (ESG): Try Pro to see estimate
- social score (ESG): Try Pro to see estimate
- governance score (ESG): Try Pro to see estimate
See more factsExtract data
Download datasets about Acurx Pharmaceuticals:
Dataset of stocks from Acurx Pharmaceuticals:
Acurx Pharmaceuticals is one of the companies in Biotechnology, companies in Health Care, companies in Staten Island, companies in the United States and 3,456,835 companies in our database.
Talking Points
- Acurx Pharmaceuticals, Inc.
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
